| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Goldenwell Biotech, Inc.
13D
GWLL · 38138N104
|
20.2% |
10/9/2026
Event 10/8/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.